INSIGHTS ON DRUG DEVELOPMENT

• Scale-Up Of A Transient rAAV Production Process

  Scalable rAAV production is achievable with a transient cell line and optimized bioreactor setup, delivering high titers and reduced impurities, now validated at 200 L scale for commercial readiness.

• 5 Trends Impacting CMOs In 2025

  In 2025, CMOs will navigate Annex 1 compliance, the BioSecure Act’s uncertainty, AI-driven drug development, supply chain challenges from tariffs, and pandemic preparedness strategies.

• Unlock The Power Of Biophysical Tools In Biotherapeutic Development

  Unlock innovation in biotherapeutics with expert insights into DSC and molecular stability. Learn how biophysical techniques can optimize formulations and enhance nucleic acid stability.

• Ask Us Anything: Cy Credille

  Learn how we balance discovery and development as an asset scales, and how the One Cambrex model keeps the original process scientists attached to a molecule from first kilos through NDA.

• If Collaboration Fuels Biopharma Innovation, Why Can't We Connect More?

  3/17/2026

  Breakthroughs thrive when biopharma teams work across silos, yet collaboration remains surprisingly difficult. Explore the barriers and why they persist. What will it take to move beyond them?

• Assessing Developability And Designing Advanceable Formulations From The Start

  1/15/2026

  Discover how early developability assessments and a quality-by-design approach can streamline formulation, reduce risk, and accelerate your path to successful, cost-effective drug development.

• Redefining OSD Development Through Foresight And Innovation

  2/12/2026

  From early formulation challenges to scale-up and commercial readiness, proactive planning and integrated capabilities help teams anticipate risks, accelerate decision-making, and maintain momentum across development.

• NGS Identification Of Internal Tandem Duplications In FLT3

  6/15/2026

  Accurately identifying genetic duplications in leukemia requires more than conventional sequencing. See how advanced enrichment and analysis approaches enable deeper insight into variant structure.

• Characterizing Quality Attributes Of GLP-1 Analogs By Light Scattering

  7/31/2025

  Explore how light scattering reveals the structural integrity, aggregation, and stability of GLP-1 analogs to advance drug formulation and enhance treatment efficacy for type 2 diabetes and obesity.